Td Asset Management Inc Corcept Therapeutics Inc Transaction History

Td Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$24.7 - $29.12 $836,070 - $985,682	33,849 Added 3.52%	994,297 $25.4 Million
Q1 2022 May 10, 2022	SELL	$16.53 - $25.21 $3.34 Million - $5.09 Million	-201,840 Reduced 17.37%	960,448 $21.6 Million
Q4 2021 Feb 10, 2022	BUY	$17.1 - $23.34 $4.35 Million - $5.94 Million	254,667 Added 28.06%	1,162,288 $23 Million
Q2 2021 Aug 11, 2021	BUY	$19.97 - $24.43 $14.7 Million - $18 Million	737,825 Added 434.54%	907,621 $18.9 Million
Q1 2021 May 14, 2021	BUY	$23.49 - $30.56 $3.99 Million - $5.19 Million	169,796 New	169,796 $4.04 Million

349

86.1M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.32B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.